308 results on '"Hobeika, Amy"'
Search Results
2. Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma
3. Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer
4. Functional CD3+CD8+PD1− T Cell Accumulation and PD-L1 Expression Increases During Tumor Invasion in DCIS of the Breast
5. Circulating CD8+CD28− suppressor T cells tied to poorer prognosis among metastatic breast cancer patients receiving adoptive T-cell therapy: A cohort study
6. Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients
7. Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patients
8. Data from Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
9. Supplementary Data from An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
10. Supplementary Figure 2 from In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
11. supplementary figure 1 from Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study
12. Supplementary Table 1 from In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
13. Figure S1 from Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
14. Supplementary legend from Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study
15. Table S3 from Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
16. Supplementary Figure 1 from In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
17. Supplementary Figure 4 from In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
18. Supplementary Figure Legends from In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
19. Supplementary Table 1 from Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
20. supplementary table 1 from Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study
21. Figure S1 from Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
22. Supplementary Figure 3 from In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
23. Data from Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
24. Data from Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
25. Table S2 from Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
26. CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine
27. Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers
28. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers
29. Analysis of Cellular Immune Responses in Cancer Vaccine Trials
30. Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma
31. Novel Recombinant Alphaviral and Adenoviral Vectors for Cancer Immunotherapy
32. Complete response of RCC to autologous T cell immunotherapy following progression on immune checkpoint inhibitor, A case report
33. Increasing vaccine potency through exosome antigen targeting
34. Creating a ‘Timeline’ of ductal carcinoma in situ to identify processes and biomarkers for progression towards invasive ductal carcinoma
35. Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease
36. HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study
37. Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation
38. Accelerated Induction of Experimental Allergic Encephalomyelitis in PL/J Mice by a Non-Vβ8-Specific Superantigen
39. Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
40. Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects
41. Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
42. Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines
43. An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
44. NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity
45. Current Immunotherapeutic Strategies in Colon Cancer
46. Recent developments in therapeutic cancer vaccines
47. Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy
48. Depletion of Human Regulatory T Cells
49. Clearance of Circulating Bacteria and Recovery of Microbiota Diversity Following Adoptive Cellular Therapy in Advanced Colorectal Cancer Patients
50. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.